Back to BCRX
RA CAPITAL MANAGEMENT, L.P. → BCRX
RA CAPITAL MANAGEMENT, L.P. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
3
Latest value
$158.3M
Q2 2026
Peak value
$158.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $123.5M |
| Q1 2026 | $150.7M |
| Q2 2026 | $158.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $158.3M | 15.83M | — | — |
| Q1 2026 | $150.7M | 15.83M | — | — |
| Q4 2025 | $123.5M | 15.83M | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M